, and PCR method. Results of the two methods were compared to find disagreement. Clinical and bacteriological characteristics of encapsulated strains were analyzed. By utilizing PCR assay, 3 (2.5%) serotype b, 1 (0.8%) serotype f and 118 (96.7%) non-typeable strains were found among 122 tested strains. Discrepancy between the results of antigenic examinations and PCR assay was found in one strain. That strain gave positive results by antigenic tests with capsular type c antiserum but it was determined to be capsular type f by PCR. No serotype b − strain was detected. All the encapsulated strains displayed biotype I. All the serotype b strains produced β -lactamase, but none of those was sulbactam/ampicillin and amoxicillin/clavulanic acid resistant. The serotype f strain was β -lactamase non-producing ampicillin susceptible. The patients suffered from respiratory infections due to encapsulated strains displayed safe clinical manifestations and good clinical responses to antibiotic treatments using β -lactams. In pre-vaccination era, PCR is considered to be a useful method for determination of serotypes of respiratory H. influenzae, which may contribute to reducing a possibility of clonal transmission of serotype b strains among children community, which is one of the potential risk factors for pediatric invasive infections.
Haemophilus influenzae (H. influenzae) is one of the most important bacterial pathogens of pediatric infections. This species is a pathogen causing variety of clinical manifestations such as meningitis, septicemia, epiglottitis, cellulites, septic arthritis, pneumonia, otitis media, sinusitis, conjunctivitis and other respiratory tract infections in children. H. influenzae can be divided into six capsular serotypes, a through f, on the basis of structurally and serologically distinct capsular polysaccharides. Capsulation (cap) locus, which is an approximately 17-kb DNA fragment, is common for all 6 serotypes of H. influenzae. This cap consists of 3 regions numbered 1, 2 and 3. The cap loci of other serotypes share region 1 and 3 but differ in region 2, which is type specific region and identical for each of the capsular types. It was described that cap locus is flanked by a 1.2-kb bridge region containing a bexA gene, which is necessary for polysaccharide export and expression. Several early studies have described a method to distinguish capsular typeable strains from non-typeable strains by amplification of this gene. The strain possesses bexA gene is classified into typeable group, in contrast, the strain lacking this gene is considered to be non-typeable (Falla et al. 1994; LaClaire et al. 2003) . Capsular H. influenzae predisposes to duplication or loss of the capsulation cassette via homologous recombination. Therefore, most of the H. influenzae type b strains contain a partial duplication of cap locus, consisting of one intact copy and the second copy with deletion of bridge region and bexA gene. In these strains, capsulation expression is lost because of deletion of the single functional copy of bexA gene, while homologous recombination between identical segments is possible (Ogilvie et al. 2001) .
The encapsulated H. influenzae type b strains are the major bacterial pathogens of invasive infections in children, while non-typeable strains mainly are pathogenic causes of respiratory tract infections (RTI). In US, the H. influenzae serotype b invasive diseases are now quite rare, because of the widespread use of a capsular type b H. influenzae conjugate vaccine (Bisgard et al. 1998) . In contrast, this kind of vaccine have not been commonly used in Japan as well as the other countries, and therefore, capsular serotype b H. influenzae remains being a leading pathogen of invasive infections in Japanese children. Moreover, incidence of the invasive infections due to H. influenzae with capsule-deficient mutants of type b strains (b − strains) has been documented (Falla et al. 1994) . In vaccine era, this type of H. influenzae is particularly important, since this is considered as one of the reasons for vaccine failure. Additionally, if the conjugated serotype b H. influenzae vaccine were widely introduced, the incidence of invasive infections due to capsular non-serotype b H. influenzae would become more prevalent.
Conventionally, serotypes of H. influenzae were detected by using Slide Agglutination Test (SAT) with 6 anti-sera, which are specific for each of the capsular serotypes. This technique is simple and gives the quick result, but it has been shown to be unreliable (Falla et al. 1994; LaClaire et al. 2003) . Recently, PCR method has been utilized for serotyping H. influenzae strains and has demonstrated high sensitivity and specificity compared with SAT (Falla et al. 1994; LaClaire et al. 2003) . It is, therefore, necessary to utilize PCR for serotyping H. influenzae strains isolated from patients with RTI. In pre-vaccination era, if the real incident rate of capsular typeable H. influenzae causing RTI was precisely investigated, pediatricians and physicians would actively control a risk factor of typeable H. influenzae invasive infections among children community.
For those reasons, the aim of the present study is to accurately detect the frequency of encapsulated H. influenzae, especially capsular serotype b, strains causing RTI in pediatric patients utilizing PCR method and to describe the clinical characteristics of those pathogenic bacteria, thereby contributing to clinical treatment and control of H. influenzae type b infections in children.
METHODS

Patient population and bacterial strains
A total of 122 H. influenzae strains clinically isolated from sputum samples of 122 pediatric patients ( 15 years of age) were collected for the present study. The patients were admitted to the hospital or visited outpatient section of the Department of Pediatrics of Chiba University Hospital and other hospitals in Chiba prefecture during 2000 through 2002. All the patients demonstrated clinical signs and symptoms of acute community acquired RTI including acute bronchitis, acute bronchiolitis and pneumonia. The H. influenzae strains were isolated from expectorated sputum samples of those patients and were identified on the basis of laboratory standard methodology described by Manual of Clinical Microbiology (Campos 1999) . 
Control bacteria
Serotyping by Slide Agglutination Tests and Counter immuno-electrophoresis
The 20-24 hours subcultures of the H. influenzae strains were tested by a commercial slide agglutination kit (Phadebact Haemophilus test; Pharmacia Co., Tokyo) to classify the strains into the serotype b, non-serotype b and non-typeable groups. Thereafter, serotypes of the capsular nonserotype b strains were determined by utility of counter-immuno-electrophoresis (CIE) with the anti-sera of serotypes a, and c to f (Denka Seiken Co., Ltd., Tokyo).
Serotyping by PCR
DNA extraction. Bacterial DNA was prepared by modification of the methods described by Falla and LaClaire (Falla et al. 1994; LaClaire et al. 2003) . Eight colonies of H. influenzae strains, which were sub-cultured for 18-20 hours onto Chocolate Agar Medium, were picked up and suspended in 25 μ l of double distilled water. The mixture was boiled at 100°C for 3 minutes and then centrifuged at 2000×g for 2 minutes. Finally, 20 μ l of supernatant was aspirated and stored at −20°C for further use.
PCR primers. A pair of primers with approximately 20 bp in length (HI-1 and HI-2), which is specific for bexA gene, was used to differentiate non-typeable H. influenzae from typeable strains. Subsequently, the PCR assay with six pairs of primers included a1, a2; b1, b2; c1, c2; d1, d2; e1, e2 and f1, f2 (Table 4) , which are specific for capsular type a through f, were performed for all the typeable strains to determine exactly serotypes. In further experiments, the non-typeable strains were subjected to PCR assay with a pair of primers b1 and b2, which are specific for capsular type b, to detect type b − strain. A strain would be considered to be type b − , if it gave a negative result by PCR with primers HI-1 and HI-2 but gave a positive result with primers b1 and b2.
PCR reaction volume. The reaction volume was 25 μ l and contained 0.2 μ M of each oligonucleotide primer, 2.5 μ l of 10×Ex Taq Buffer, 2 μ l of dNTP mix (concentration: 200 μ M of each dNTP), 1.5 μ l of template DNA solution (previously described), 1.0 U of Taq polymerase (TAKARA BIO INC., Shiga) and 16 μ l of double distilled water.
PCR condition. The mixture was (processed) for 25 cycles in the programmable thermal cycler (Peltier Thermal Cycler). The cycling parameters consist of 1 minute of denature at 94°C, 1 minute of annealing at 60°C and 1 minute of extension at 72°C. The final cycle of incubation was 10 minutes at 72°C. The 10 μ l of final PCR production was resolved by electrophoresis through 2% agarose in Tris-Cl-borate (EDTA) and visualized by ethidium bromide staining. The fragment sizes of amplicons were compared with those of positive control and DNA micromarker (E840) (AMRESCO Inc., Solon, OH, USA).
Susceptibility testing
Antibiotic susceptibility of H. influenzae was determined by assessing minimum inhibitory concentration (MIC) to the antibiotic agents: ampicillin (AMP), ampicillin/sulbactam (SAM), amoxicillin/clavulanic acid (AMC) and cefotaxime (CTX). MIC was measured using Agar Dilution Susceptibility Test according to the methods described by National Committee for Clinical Laboratory Standards and Japanese Society for Chemotherapy (NCCLS 1997; Goto et al. 1981) Correlation between the results of SAT+CIE and PCR assay was evaluated by analysis of sensitivity (100%-false negative rate) and specificity (100%-false positive rate) of SAT+CIE findings by considering PCR results as the referent standards.
Statistic analysis was carried out with Chi square test (ystat2002 software). Table 1 shows sources of the 122 strains by patient's gender, sex and diagnosis. Among the total 122 strains, isolation rates from male and female were 59.8% and 40.2%, respectively. There was no statistic difference between isolation rates from male and female (p=0.99). Most of the strains were isolated from patients of 6-10 years old (p<0.01). In addition, the strains were mainly isolated from patients suffered from acute bronchitis with the rate of 73.8% (p<0.01). Of the total 4 encapsulated strains, 3 strains were isolated from patients with acute bronchitis. Table 2 shows correlation between the results of antigenic examinations and PCR for serotyping H. influenzae strains. By utilizing Phadebact Haemophilus test, 3 (2.5%) serotype b strains, 1 (0.8%) capsular non-type b strain and 118 (96.7%) non-typeable strains were found. On the basis of CIE method with 6 antisera of serotype a to f, the non-serotype b strain only gave positive result with antiserum of serotype c.
RESULTS
Using PCR assay with the capsular-specific primers HI-1 and HI-2, a 343-bp DNA sequence that is specific for bexA gene was amplified in 4 strains (Fig. 1A) . Subsequently, those strains were subjected to PCR with 6 pairs of typespecific primers. The results showed that among those strains, 3 strains produced specific DNA sequences amplified with primers b1 and b2 (Fig.1B) , and 1 strain demonstrated a specific DNA sequence amplified with primers f1 and f2 (Fig.1C) . In the further experiments, the PCR with the primers b1and b2 was performed for all the remainder of 118 non-typeable strains to detect type b − strain. However, the result revealed that none of 118 non-typeable strains demonstrated characteristics of type b − strain. In this study, discrepancy was found between the results of antigenic examinations and PCR method. By using SAT and CIE, one strain was determined to be serotype c H. influenzae, while that strain was identified as serotype f by PCR assay. That strain was retested with PCR assay and SAT + CIE in the same conditions with the initial examinations, however, no different result was found. Moreover, the current study indicated that no discrepancy between the results of antigenic examinations and PCR was found among the nontypeable and type b strains.
On the basis of the data shown in Table 2 , correlation between antigenic tests and PCR was analyzed. Regarding PCR results as the referent standards, false negative rate and sensitivity of antigenic examinations for serotyping typeable strains are considered to be 1/4 (25.0%) and 3/4 (75.0%), respectively. By similar consideration, false positive rate and specificity of these techniques are 25.0% and 75.0%, respectively. In overall, false negative rate, sensitivity, false positive rate and specificity of antigenic tests for serotype-determination of all the strains are considered to be 1/121 (0.8%), 121/122 (99.2%), 1/121 (0.8%) and 121/122 (99.2%), respectively.
Clinical characteristics of respiratory encapsulated H. influenzae strains are demonstrated in Table 3 . Among 4 patients with RTI due to encapsulated H. influenzae, 3 patients suffered from acute bronchitis and one patient suffered from pneumonia. All the encapsulated strains were biotype I. In addition, all the 3 serotype b strains produced β -lactamase and demonstrated MIC values of ampicillin (AMP) ranging from 6.25 to >12.5 μ g/ml. Fortunately, those serotype b strains were susceptible with sulbactam/ampicillin (SAM) and amoxicillin/clavulanic acid (AMC), with SAM-MICs and AMC-MICs ranged from 0.8-1.56 μ g/ml. The encapsulated serotype f strain was a bacterial pathogen of acute bronchitis and demonstrated characteristics of β -lactamase non-producing ampicillin susceptible strains, with AMP-MIC of 0.4 μ g/ml. For the 3 patients with RTI caused by serotype b strains, clinical symptoms were improved and the bacterial pathogens were eliminated by 5-day administrations of cefcapene, cefditoren, and SAM, respectively. In addition, the serotype f strain caused RTI in one patient was eradicated with 5-day treatment of AMP.
DISCUSSION
Traditionally, SAT has been utilized for serotyping H. influenzae strains that cause invasive infections and RTI. However, the previous studies indicated that this technique has shown to be unreliable (Falla et al. 1994; LaClaire et al. 2003) . Unreliability of this technique might be due to se- Fig. 1 . A: Agarose gel electrophoresis of PCR products from 4 encapsulated H. influenzae strains with capsular-specific primers (HI-1 and HI-2). Lane M contains DNA micro-marker (E840). Lanes 1 to 4 contain PCR products from 4 encapsulated strains. From those strains, a 343 bp DNA fragments was amplified with capsular specific primers (HI-1, HI-2). Lane 5 contains PCR product from a nontypeable strain representing a negative control. B: Agarose gel electrophoresis of PCR products from 4 encapsulated H. influenzae strains with the capsular type b-specific primers. Lane M contains DNA micro-marker (E840). Lanes 1 to 3 contain PCR products from 3 serotype b strains. Lane 4 contains PCR product from a serotype f strain, which gave a negative response with serotype b-specific primers. C: Agarose gel electrophoresis of PCR products from the serotype f strain with 6 pairs of typespecific primers was shown. Lane M designated to show DNA micro-marker (E840). Lanes 1 to 6 contain PCR products from the serotype f strain with the type-specific primers for serotype a through f, respectively. A specific DNA fragment is only shown in lane 6, which was amplified with type f specific primers.
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rological cross-reactions, technical practice and/or antiserum quality. Recently, PCR method for determination of serotypes of H. influenzae, which was initially developed by Falla et al. (1994) , has demonstrated significantly high sensitivity and specificity comparing with antigenic examinations. The PCR technique used in the present study is established by modification of the two methods described by Falla et al. (1994) and LaClaire et al. (2003) . The first round of PCR with capsular specific primers was used as a screening test for all strains to differentiate the capsular typeable strains from non-typeable strains. In the second round of PCR, each of capsular typeable strains, which gave positive results in the initial round, was examined with 6 pairs of type specific primers to exactly identify the serotypes. In addition, the strains that gave negative results by first PCR round were tested in further experiments with type b specific primers to detect b − strain. Correlation rates between the results of SAT and PCR method also has been indicated in previous study. The results of SAT and PCR were compatible in only 60% of tested isolates. In addition, 54 of 141 strains were determined as serotypeable strains by SAT, but PCR method with either capsular-specific primers or typespecific primers gave negative results. This study also indicated that no discrepancy between the results of SAT and PCR was found among nontypeable strains (LaClaire et al. 2003) . Finding of the present study is consistent with the previous data. The disagreement between SAT and PCR results in this study was found in only one capsular non-type b strain, which gave positive result by SAT with antiserum of serotype c, but it was determined to be serotype f by PCR assay. We presume that this discrepancy may be due to the low sensitivity of antiserum, resulting in difficulty for interpretation of agglutination test. However, this hypothesis should be confirmed in further study.
In a previous report, the incidence of type b − strain has been documented. That study indicated that 6 of 172 tested strains demonstrated characteristics of serotype b − strains (Falla et al. 1994) . However, in the other study, the authors did not detect any strain of that type of H. influenzae (LaClaire et al. 2003) . It was thought that b − strain of H. influenzae is a capsular-deficient mutant of serotype b strains. Therefore, isolation rate of that type of H. influenzae seems to be quite low. Especially, among the strains isolated from pediatric patients with RTI, which are mainly non-typeable, the frequency of b − strains might be extremely low. For those considerations, in order to detection of the real frequency of b − strains that cause RTI, a much larger population of H. influenzae needs to be set in further study.
In Japan, it was reported that serotype b H.
influenzae was not frequently found among the strains isolated from sputum samples of patients with RTI. More than 90% of the respiratory strains were non-typeable (Uehara et al. 1985) .
For the other study of 1725 H. influenzae strains isolated from RTI of pediatric patients during 1980-1991, proportion of serotype b strains was 2.6% of the total strains (Nakamura et al. 1995) . In addition, it was shown that the proportion of serotype b strains was 4.5% of the total H. influenzae strains isolated from all sources (Watanabe et al. 2000) . Similarly, a study in Saudi Arabia indicated that only 4 serotype b strains were found among total 129 H. influenzae strains isolated from RTI (Abdel-Raman et al. 2000) . In contrast, a study conducted in India revealed that 64.0% of the H. influenzae strains isolated from respiratory tract samples (throat swab and sputum) were type b, and the strain with other capsular serotype was not observed (Sharma et al. 2002) . The isolation rate of encapsulated serotype b strains found in this study correlated to the previous data reported in Japan and Saudi Arabia but lower than that in India. Moreover, it was known well that the strains of H. influenzae frequently colonized respiratory tract of children. In the environment of close contacts, the colonization rate is much higher (Pincipi et al. 1999) . Especially, the clonal dissemination of serotype b H. influenzae is possibly occurred among children community, while that phenomenon seems to be not happened with non-typeable H. influenzae ). Although encapsulated strains of H. influenzae are not the serious pathogens of RTI in pediatric patients and their incident rate in respiratory airways is really low, these pathogenic bacteria may be the potential risk factors of invasive infections in children. In addition, the patients suffered from RTI due to those types of pathogenic bacteria may likely server as the reservoirs for further bacterial disseminations among children community in prevaccination era. Therefore, we suggest that PCR method is not only valuable for determination of serotypes of H. influenzae strains isolated from blood, cerebrospinal fluid and nasopharyngeal samples of the patients suffered from meningitis and septicemia, but it also should be used for accurately detecting serotypes of the strains isolated from respiratory tract of the children, who had closely contacted with patients suffered from H. influenzae type b invasive infections. On the basis of PCR results, pediatricians and physicians would decide an appropriate proposal for completely eradicating this pathogen from any sample sources of those patients and controlling a possibility of clonal dissemination of type b H. influenzae among children community, which is considered to be one of risk factors of pediatric invasive infections.
This study supports the conclusion of the Falla et al. (1994) and LaClaire et al. (2003) on the high sensitivity and specificity of PCR assay as well as advantages of this method in clinical management and control of infections due to H. influenzae. However, the other reliable techniques for serotyping of H. influenzae, such as capsulation loci genotyping assay and method for copy number of cap (Ogilvie et al. 2001) , should be used in combination with PCR for confirming the results of PCR and antigenic tests in the further study.
In conclusion, we confirm the fact that the frequency of encapsulated H. influenzae causing RTI in children is quite low. In addition, capsular typeable strains of H. influenzae are not the serious pathogens of RTI in children. However, in pre-vaccination era the real incident rate of encapsulated strains causing pediatric RTI should be accurately investigated in order to monitor and control one of the possible risk factors of invasive infections in children. PCR for determination of serotypes of H. influenzae has high sensitivity and specificity comparing with antigenic examination and should be employed in clinical management and control of H. influenzae invasive infections in children.
